p.97 抽出テキスト

1 diabetes. Diabetologia 2018;61:1935–1945. https://doi.org/10.1007/s00125-018- 4648-5 800. Kalyani RR, Cannon CP, Cherrington AL, Coustan DR, De Boer IH, Feldman H, et al. Professional practice committee: standards of medical care in Diabetes-2018. Diabetes Care 2018;41:S3. https://doi.org/10.2337/dc18-SPPC01 801. Mathieu C, Zinman B, Hemmingsson JU, Woo V, Colman P, Christiansen E, et al. Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes: the ADJUNCT ONE treat-to-target randomized trial. Diabetes Care 2016;39: 1702–1710. https://doi.org/10.2337/dc16-0691 802. Frandsen CS, Dejgaard TF, Holst JJ, Andersen HU, Thorsteinsson B, Madsbad S. Twelve-week treatment with liraglutide as add-on to insulin in normal-weight patients with poorly controlled type 1 diabetes: a randomized, placebo-controlled, doubleblind parallel study. Diabetes Care 2015;38:2250–2257. https://doi.org/10.2337/dc15- 1037 803. Yamada T, Shojima N, Noma H, Yamauchi T, Kadowaki T. Sodium-glucose co-transporter-2 inhibitors as add-on therapy to insulin for type 1 diabetes mellitus: systematic review and meta-analysis of randomized controlled trials. Diabetes Obes Metab 2018;20:1755–1761. https://doi.org/10.1111/dom.13260 804. Fattah H, Vallon V. The potential role of SGLT2 inhibitors in the treatment of type 1 diabetes mellitus. Drugs 2018;78:717–726. https://doi.org/10.1007/s40265-018-0901-y 805. ACE Inhibitors in Diabetic Nephropathy Trialist Group. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. Ann Intern Med 2001;134:370–379. https://doi.org/10.7326/0003-4819-134-5-200103060-00009 806. Lambrinou E, Hansen TB, Beulens JW. Lifestyle factors, self-management and patient empowerment in diabetes care. Eur J Prev Cardiol 2019;26(2_suppl):55–63. https://doi. org/10.1177/2047487319885455 807. Lambrinou E, Kyriakou M, Lakatamitou I, Angus N, Khatib R, Vellone E, et al. An integrative review on facilitators and barriers in delivering and managing injectable therapies in chronic conditions: a part of the ACNAP project ‘injectable medicines among patients with cardiovascular conditions’. Eur J Cardiovasc Nursing 2020;19:663–680. https://doi.org/10.1177/1474515120939007 808. Jennings C, Astin F. A multidisciplinary approach to prevention. Eur J Prev Cardiol 2017; 24(3_suppl):77–87. https://doi.org/10.1177/2047487317709118 809. Chen Y, Tian Y, Sun X, Wang B, Huang X. Effectiveness of empowerment-based intervention on HbA1c and self-efficacy among cases with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Medicine (Baltimore) 2021;100: e27353. https://doi.org/10.1097/MD.0000000000027353 810. Galati G, Sabouret P, Germanova O, Bhatt DL. Women and diabetes: preventing heart disease in a new era of therapies. Eur Cardiol 2021;16:e40. https://doi.org/10.15420/ecr. 2021.22 811. Deakin TA, McShane CE, Cade JE, Williams R. Group based training for selfmanagement strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005;2:CD003417. https://doi.org/10.1002/14651858.CD003417.pub2 812. Steinsbekk A, Rygg L, Lisulo M, Rise MB, Fretheim A. Group based diabetes selfmanagement education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis. BMC Health Services Res 2012;12:213. https://doi.org/10.1186/1472-6963-12-213 813. Lo C, Toyama T, Wang Y, Lin J, Hirakawa Y, Jun M, et al. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease. Cochrane Database Syst Rev 2018;9:CD011798. https://doi.org/10.1002/14651858.CD011798.pub2 814. Tan SM, Han E, Quek RYC, Singh SR, Gea-Sánchez M, Legido-Quigley H. A systematic review of community nursing interventions focusing on improving outcomes for individuals exhibiting risk factors of cardiovascular disease. J Adv Nursing 2020;76:47–61. https://doi.org/10.1111/jan.14218 815. Snaterse M, Dobber J, Jepma P, Peters RJ, Ter Riet G, Boekholdt SM, et al. Effective components of nurse-coordinated care to prevent recurrent coronary events: a systematic review and meta-analysis. Heart 2016;102:50–56. https://doi.org/10.1136/ heartjnl-2015-308050 816. Carrington MJ, Zimmet PZ. Nurse co-ordinated health and lifestyle modification for reducing multiple cardio-metabolic risk factors in regional adults: outcomes from the MODERN randomized controlled trial. Eur J Cardiovasc Nursing 2022;21:26–35. https://doi.org/10.1093/eurjcn/zvab042 817. Seidu S, Cos X, Brunton S, Harris S, Jansson SP, Mata-Cases M, et al. A disease state approach to the pharmacological management of type 2 diabetes in primary care: a position statement by Primary Care Diabetes Europe. Primary Care Diabetes 2021; 15:31–51. https://doi.org/10.1016/j.pcd.2020.05.004 818. Goldwater D, Wenger NK. Patient-centered care in geriatric cardiology. Trends Cardiovasc Med 2023;33:13–20. doi:10.1016/j.tcm.2021.11.001 819. Ekman I, Wolf A, Olsson L-E, Taft C, Dudas K, Schaufelberger M, et al. Effects of person-centred care in patients with chronic heart failure: the PCC-HF study. Eur Heart J 2012;33:1112–1119. https://doi.org/10.1093/eurheartj/ehr306 820. Elissen AM, Hertroijs DF, Schaper NC, Bosma H, Dagnelie PC, Henry RM, et al. Differences in biopsychosocial profiles of diabetes patients by level of glycaemic control and health-related quality of life: the Maastricht Study. PLoS One 2017;12: e0182053. https://doi.org/10.1371/journal.pone.0182053 821. Odgers-Jewell K, Ball L, Kelly J, Isenring E, Reidlinger D, Thomas R. Effectiveness of group-based self-management education for individuals with type 2 diabetes: a systematic review with meta-analyses and meta-regression. Diabet Med 2017;34:1027–1039. https://doi.org/10.1111/dme.13340 822. Coulter A, Entwistle VA, Eccles A, Ryan S, Shepperd S, Perera R. Personalised care planning for adults with chronic or long-term health conditions. Cochrane Database Syst Rev 2015;2015:CD010523. https://doi.org/10.1002/14651858.CD010523.pub2 823. Lewin S, Skea Z, Entwistle VA, Zwarenstein M, Dick J. Interventions for providers to promote a patient-centred approach in clinical consultations. Cochrane Database Syst Rev 2001;4:CD003267. https://doi.org/10.1002/14651858.CD003267 824. Ekman I, Swedberg K, Taft C, Lindseth A, Norberg A, Brink E, et al. Person-centered care—ready for prime time. Eur J Cardiovasc Nursing 2011;10:248–251. https://doi.org/ 10.1016/j.ejcnurse.2011.06.008 825. Aquino JA, Baldoni NR, Flôr CR, Sanches C, Oliveira CDL, Alves GCS, et al. Effectiveness of individual strategies for the empowerment of patients with diabetes mellitus: a systematic review with meta-analysis. Primary Care Diabetes 2018;12: 97–110. https://doi.org/10.1016/j.pcd.2017.10.004 826. Cox DJ, Taylor AG, Singh H, Moncrief M, Diamond A, Yancy WS Jr, et al. Glycemic load, exercise, and monitoring blood glucose (GEM): a paradigm shift in the treatment of type 2 diabetes mellitus. Diabetes Res Clin Pract 2016;111:28–35. https://doi.org/10. 1016/j.diabres.2015.10.021 827. Schulman-Green D, Jaser SS, Park C, Whittemore R. A metasynthesis of factors affecting self-management of chronic illness. J Adv Nursing 2016;72:1469–1489. https://doi. org/10.1111/jan.12902 828. Dunn JA, Chokron Garneau H, Filipowicz H, Mahoney M, Seay-Morrison T, Dent K, et al. What are patient preferences for integrated behavioral health in primary care? J Primary Care Community Health 2021;12:21501327211049053. https://doi.org/10. 1177/21501327211049053 829. Piepoli MF, Villani GQ. Lifestyle modification in secondary prevention. Eur J Prev Cardiol 2017;24(3_suppl):101–107. https://doi.org/10.1177/2047487317703828 830. Kyriakou M, Samara A, Philippou K, Lakatamitou I, Lambrinou E. A qualitative metasynthesis of patients with heart failure perceived needs. Rev Cardiovasc Med 2021; 22:853–864. https://doi.org/10.31083/j.rcm2203091 831. Greenwood DA, Blozis SA, Young HM, Nesbitt TS, Quinn CC. Overcoming clinical inertia: a randomized clinical trial of a telehealth remote monitoring intervention using paired glucose testing in adults with type 2 diabetes. J Med Internet Res 2015;17:e4112. https://doi.org/10.2196/jmir.4112 832. McCarrier KP, Ralston JD, Hirsch IB, Lewis G, Martin DP, Zimmerman FJ, et al. Web-based collaborative care for type 1 diabetes: a pilot randomized trial. Diabetes Technol Ther 2009;11:211–217. https://doi.org/10.1089/dia.2008.0063 833. Sigurdardottir AK, Benediktsson R, Jonsdottir H. Instruments to tailor care of people with type 2 diabetes. J Adv Nursing 2009;65:2118–2130. https://doi.org/10.1111/j.1365- 2648.2009.05040.x 834. Wu H-C, Tan S, Yeh C, Wu S. A study on efficacy of empowerment training among diabetes patients. Life Sci J 2011;8:215–219. https://doi.org/10.7537/marslsj080311.39 835. Clayton JA, Gaugh MD. Sex as a biological variable in cardiovascular diseases: JACC focus seminar 1/7. J Am College Cardiol 2022;79:1388–1397. https://doi.org/10.1016/j. jacc.2021.10.050 836. Nussbaum SS, Henry S, Yong CM, Daugherty SL, Mehran R, Poppas A. Sex-specific considerations in the presentation, diagnosis, and management of ischemic heart disease: JACC focus seminar 2/7. J Am College Cardiol 2022;79:1398–1406. https://doi.org/ 10.1016/j.jacc.2021.11.065 837. Gaudino M, Di Franco A, Cao D, Giustino G, Bairey Merz CN, Fremes SE, et al. Sex-related outcomes of medical, percutaneous, and surgical interventions for coronary artery disease: JACC focus seminar 3/7. J Am College Cardiol 2022;79:1407–1425. https://doi.org/10.1016/j.jacc.2021.07.066 838. Aktaa S, Batra G, Wallentin L, Baigent C, Erlinge D, James S, et al. European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes. Eur Heart J Qual Care Clin Outcomes 2022;8: 4–13. https://doi.org/10.1093/ehjqcco/qcaa069 839. Minchin M, Roland M, Richardson J, Rowark S, Guthrie B. Quality of care in the United Kingdom after removal of financial incentives. N Engl J Med 2018;379:948–957. https:// doi.org/10.1056/NEJMsa1801495 840. Song Z, Ji Y, Safran DG, Chernew ME. Health care spending, utilization, and quality 8 years into global payment. N Engl J Med 2019;381:252–263. https://doi.org/10.1056/ NEJMsa1813621 841. Arbelo EC, Aktaa S, Bollmann A, D’Avila A, Drossart I, Dwight J, et al. Quality indicators for the care and outcomes of adults with atrial fibrillation: Task Force for the development of quality indicators in atrial fibrillation of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC): developed in collaboration with the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS). Europace 2021;23: 494–495. https://doi.org/10.1093/europace/euaa253 842. Schiele F, Aktaa S, Rossello X, Ahrens I, Claeys MJ, Collet J-P, et al. 2020 update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC

ESC Guidelines                                                                                                                                                                                          4139

Downloaded from academic.oup.com/eurheartj/article/44/39/4043/7238227 by guest on 07 October 2026